Marathon Petroleum's 0.79% Rise on $330M Volume (Rank 308th) as Institutional Buys Clash with Insider Sales

Generated by AI AgentAinvest Volume Radar
Thursday, Aug 28, 2025 7:33 pm ET1min read
Aime RobotAime Summary

- Marathon Petroleum's stock rose 0.79% on $330M volume (rank 308th), reflecting mixed investor sentiment amid institutional and insider trading activity.

- Institutional investors showed divergent moves: Redwood cut 7.9% stake while Freedom added 18.3%, contrasting insider sales of 27-28% by directors Kim Rucker and Molly Benson.

- Q2 earnings exceeded estimates at $3.96/share despite 11.1% revenue decline, maintaining 1.58% net margin and a 2.1% dividend yield.

- Analysts remain divided: Mizuho raised $184 target while Wolfe downgraded to "peer perform," with consensus at $185.29 and 8 "Buy" vs 8 "Hold" ratings.

On August 28, 2025,

(MPC) traded with a volume of $330 million, ranking 308th in market activity. The stock rose 0.79%, reflecting mixed investor sentiment amid recent institutional and insider transactions.

Institutional investors reshaped their positions during the first quarter.

Investment Management LLC reduced its stake by 7.9%, holding 26,099 shares valued at $3.8 million. Conversely, Freedom Investment Management Inc. increased its holdings by 18.3%, while Southeast Asset Advisors LLC and Enterprise Financial Services Corp. entered new positions. Jump Financial LLC and SVB Wealth LLC also boosted their stakes, with the latter’s ownership rising 9.9%.

Insider activity included significant sales. Director Kim Rucker sold 7,392 shares, a 28.07% reduction in her holdings, while Molly Benson offloaded 10,879 shares, trimming her position by 27.49%. These transactions highlight ongoing internal divestments, which could signal strategic reallocations or confidence shifts.

Marathon’s Q2 earnings report showed resilience, with $3.96 per share, surpassing estimates. Despite a 11.1% year-over-year revenue decline, the company maintained a 1.58% net margin. A $0.91 quarterly dividend was declared, yielding 2.1% annually, aligning with its 54.01% payout ratio.

Analysts remain divided.

raised its price target to $184, while Wolfe Research downgraded to “peer perform.” Morgan Stanley’s $182 target and “overweight” rating contrast with ISI’s “in-line” stance. The consensus averages $185.29, with eight “Buy” and eight “Hold” ratings, reflecting cautious optimism.

Query limit exceeded.

Comments



Add a public comment...
No comments

No comments yet